Btim Corp Decreased Cr Bard Inc (NYSE:BCR) Stake By $13.89 Million

October 13, 2017 - By Hazel Jackson

Investors sentiment decreased to 0.58 in Q2 2017. Its down 0.30, from 0.88 in 2017Q1. It dived, as 99 investors sold BCR shares while 273 reduced holdings. 103 funds opened positions while 111 raised stakes. 55.14 million shares or 10.97% less from 61.93 million shares in 2017Q1 were reported. Advantus Capital Mngmt invested in 7,475 shares. Chase Inv Counsel Corp holds 7,844 shares or 1.2% of its portfolio. American Century Incorporated has invested 0.02% in C R Bard Inc (NYSE:BCR). Evercore Wealth Mgmt Ltd Liability has invested 0.01% of its portfolio in C R Bard Inc (NYSE:BCR). Spinnaker Trust holds 0.03% or 787 shares in its portfolio. Bessemer Inc has invested 0.2% in C R Bard Inc (NYSE:BCR). Hartford Financial Mngmt has 10 shares for 0% of their portfolio. Northwestern Mutual Wealth Management invested 0% of its portfolio in C R Bard Inc (NYSE:BCR). Bbt Limited Liability Co holds 33,000 shares. 83,772 are owned by Prelude Management Limited Liability Com. Credit Suisse Ag invested 0.05% in C R Bard Inc (NYSE:BCR). Savant Limited Liability Corporation reported 1,621 shares. The Japan-based Norinchukin Retail Bank The has invested 0.03% in C R Bard Inc (NYSE:BCR). Kentucky Retirement Sys holds 0.11% or 4,642 shares in its portfolio. Tig Advsrs Limited Liability Co invested 2.84% in C R Bard Inc (NYSE:BCR).

Btim Corp decreased its stake in Cr Bard Inc (NYSE:BCR) by 18.3% based on its latest 2017Q3 regulatory filing with the SEC. Btim Corp sold 43,412 shares as the company’s stock rose 26.87% with the market. The institutional investor held 193,872 shares of the health care company at the end of 2017Q3, valued at $62.14 million, down from 237,284 at the end of the previous reported quarter. Btim Corp who had been investing in Cr Bard Inc for a number of months, seems to be less bullish one the $23.50 billion market cap company. The stock rose 0.40% or $1.3 reaching $323.41. About 300,685 shares traded. C R Bard Inc (NYSE:BCR) has risen 40.70% since October 13, 2016 and is uptrending. It has outperformed by 24.00% the S&P500.

Btim Corp, which manages about $6.42B US Long portfolio, upped its stake in Tootsie Roll Inds (NYSE:TR) by 371,118 shares to 435,583 shares, valued at $16.55M in 2017Q3, according to the filing.

C R Bard Inc (NYSE:BCR) Ratings Coverage

Among 15 analysts covering CR Bard (NYSE:BCR), 4 have Buy rating, 0 Sell and 11 Hold. Therefore 27% are positive. CR Bard has $31700 highest and $190 lowest target. $252.67’s average target is -21.87% below currents $323.41 stock price. CR Bard had 30 analyst reports since August 27, 2015 according to SRatingsIntel. The stock has “Hold” rating by Zacks on Monday, September 7. Raymond James upgraded C R Bard Inc (NYSE:BCR) rating on Thursday, January 5. Raymond James has “Strong Buy” rating and $265 target. As per Wednesday, April 26, the company rating was downgraded by Wells Fargo. The stock of C R Bard Inc (NYSE:BCR) has “Hold” rating given on Wednesday, July 27 by Jefferies. The firm earned “Neutral” rating on Thursday, August 27 by Goldman Sachs. The rating was maintained by Needham with “Hold” on Friday, September 22. The stock has “Hold” rating by BMO Capital Markets on Thursday, August 31. The firm earned “Sector Weight” rating on Thursday, August 27 by KeyBanc Capital Markets. The stock of C R Bard Inc (NYSE:BCR) earned “Hold” rating by Jefferies on Thursday, June 29. The firm has “Hold” rating by Cowen & Co given on Friday, July 28.

C. R. Bard, Inc. is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The company has market cap of $23.50 billion. The Firm operates through the manufacture and sale of medical devices segment. It has a 42.45 P/E ratio. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis.

Another recent and important C R Bard Inc (NYSE:BCR) news was published by which published an article titled: “EU mergers and takeovers (Oct 13)” on October 13, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.